CS logo
small CS logo
Worcestershire Royal Hospital

Worcester, United Kingdom
General hospital in Worcester, England
Charles Hastings Way, Worcester WR5 1DD

About Worcestershire Royal Hospital


Worcestershire Acute Hospitals NHS Trust is an NHS trust which runs three hospitals in Worcestershire, England: The Alexandra Hospital, Redditch, Kidderminster Hospital and Treatment Centre in Kidderminster, Evesham hospital Burlingham ward in Evesham and the Worcestershire Royal Hospital in Worcester.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Institute of Cancer Research, United Kingdom
4
Medical Research Council
3
University of Leeds
3
Amgen
2
Cancer Research Campaign Clinical Trials Centre
2
University College, London
2
University Hospital Southampton NHS Foundation Trust
2
University of Birmingham
2
Wales Cancer Trials Unit
2
Biosensors Europe SA
1
Cambridge University Hospitals NHS Foundation Trust
1
Total Rows: 29

Clinical Trials at Worcestershire Royal Hospital


During the past decade, Worcestershire Royal Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33332233112200110000000000000011Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
1999-10-01
2009-02-01
Completed
Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery
2001-08-01
Unknown status
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
2004-04-01
Unknown status
2,000
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2004-03-01
2010-07-01
Completed
1,300
Radiation Therapy in Treating Women With Localized Breast Cancer
2004-10-05
2017-03-09
Completed
917
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
2004-09-01
2022-05-01
Unknown status
600
Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
2005-03-01
Unknown status
2,421
Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
2005-06-01
2009-12-01
Completed
500

Rows per page:

1–42 of 42

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Worcestershire Royal Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 4 trials, followed by "Medical Research Council" with 3 trials sponsored, "University of Leeds" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Cancer Research Campaign Clinical Trials Centre" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Worcestershire Royal Hospital" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.
Created with Highcharts 11.1.0Top Leading SponsorsInstitute of CancerResearch, UnitedKingdom: 4Institute of CancerResearch, UnitedKingdom: 4Medical Research Council: 3Medical Research Council: 3University of Leeds: 3University of Leeds: 3Amgen: 2Amgen: 2Cancer ResearchCampaign Clinical TrialsCentre: 2Cancer ResearchCampaign Clinical TrialsCentre: 2University College, London: 2University College, London: 2University HospitalSouthampton NHSFoundation Trust: 2University HospitalSouthampton NHSFoundation Trust: 2University of Birmingham: 2University of Birmingham: 2Wales Cancer Trials Unit: 2Wales Cancer Trials Unit: 2Biosensors Europe SA: 1Biosensors Europe SA: 1

Created with Highcharts 11.1.0Top CollaboratorsCancer Research UK: 7Cancer Research UK: 7Celgene: 2Celgene: 2National Institute forHealth Research, UnitedKingdom: 2National Institute forHealth Research, UnitedKingdom: 2Takeda: 2Takeda: 2AstraZeneca: 1AstraZeneca: 1Australian and NewZealand Intensive CareResearch Centre: 1Australian and NewZealand Intensive CareResearch Centre: 1Berry Consultants: 1Berry Consultants: 1Chief Scientist Office ofthe ScottishGovernment: 1Chief Scientist Office ofthe ScottishGovernment: 1GlaxoSmithKline: 1GlaxoSmithKline: 1Global Coalition forAdaptive Research: 1Global Coalition forAdaptive Research: 1

Clinical Trials Conditions at Worcestershire Royal Hospital


According to Clinical.Site data, the most researched conditions in "Worcestershire Royal Hospital" are "Breast Cancer" (9 trials), "Colorectal Cancer" (5 trials), "Multiple Myeloma" (3 trials), "Lung Cancer" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "Worcestershire Royal Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Worcestershire Royal Hospital


Most popular intervention types in "Worcestershire Royal Hospital" are "Drug" (28 trials), "Procedure" (12 trials), "Radiation" (8 trials), "Biological" (7 trials) and "Other" (7 trials). Other intervention types were less common.
The name of intervention was led by "capecitabine" (5 trials), "adjuvant therapy" (4 trials), "radiation therapy" (4 trials), "cetuximab" (3 trials) and "fluorouracil" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Worcestershire Royal Hospital


The vast majority of trials in "Worcestershire Royal Hospital" are 34 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Worcestershire Royal Hospital


Currently, there are NaN active trials in "Worcestershire Royal Hospital". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Worcestershire Royal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Worcestershire Royal Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 23Phase 3: 23Phase 2: 12Phase 2: 12Not Applicable: 10Not Applicable: 10

Created with Highcharts 11.1.0Trials StatusCompleted: 19Completed: 19Unknown status: 10Unknown status: 10Recruiting: 7Recruiting: 7Active, not recruiting: 6Active, not recruiting: 6